IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q1 2024 Holdings

Filed 2024-05-14 | 3 holdings | $10.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$5.0M630,00048.3%
Werewolf Therapeutics Inc(HOWL)COM95075A107$3.8M589,10236.9%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$1.5M642,20414.8%